IMNM
Immunome Inc.Company with tickers: IMNM
CIK
1472012
CUSIP
45257U108
Shares Outstanding
113,250,394
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $0 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $59,331,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Research & Development | $46,381,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Operating Income | $-59,331,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Net Income | $-53,839,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Basic) | $-0.48 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Diluted) | $-0.48 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |